| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.952 | 0.001 | 0.952 | Dopamine transporter inhibitor | 0.8 0.001 DBMET00358 0.859 0.001 DB01515 0.863 0.001 DBMET00645 | ||
| 0.932 | 0.001 | 0.932 | Dopamine uptake inhibitor | 0.69 0.002 DBMET00358 0.736 0.002 DB01515 0.857 0.002 DBMET00645 | ||
| 0.888 | 0.003 | 0.89 | Psychostimulant | 0.367 0.028 DBMET00358 0.859 0.003 DB01515 0.89 0.003 DBMET00645 | DBMET00645 | |
| 0.825 | 0.002 | 0.927 | Anesthetic local | 0.507 0.004 DBMET00358 0.64 0.003 DB01515 0.927 0.002 DBMET00645 | DBMET00645 | |
| 0.791 | 0.003 | 0.791 | 5 Hydroxytryptamine uptake inhibitor | 0.759 0.003 DBMET00358 0.7 0.003 DB01515 0.729 0.003 DBMET00645 | ||
| 0.751 | 0.003 | 0.807 | Anesthetic general | 0.669 0.004 DB01515 0.807 0.002 DBMET00645 | DBMET00645 | |
| 0.743 | 0.005 | 0.855 | Spasmolytic | 0.231 0.1 DBMET00358 0.712 0.005 DB01515 0.855 0.004 DBMET00645 | DBMET00645 | |
| 0.674 | 0.003 | 0.74 | Acetylcholine M1 receptor antagonist | 0.336 0.01 DBMET00358 0.606 0.003 DB01515 0.74 0.003 DBMET00645 | DBMET00645 | |
| 0.672 | 0.003 | 0.701 | Cholinergic antagonist | 0.29 0.015 DBMET00358 0.6 0.004 DB01515 0.701 0.003 DBMET00645 | DBMET00645 | |
| 0.671 | 0.003 | 0.694 | Acetylcholine antagonist | 0.285 0.015 DBMET00358 0.594 0.004 DB01515 0.694 0.003 DBMET00645 | DBMET00645 | |
| 0.654 | 0.003 | 0.679 | Adrenaline uptake inhibitor | 0.679 0.002 DBMET00358 0.566 0.003 DB01515 0.591 0.003 DBMET00645 | DBMET00358 | |
| 0.579 | 0.003 | 0.622 | Acetylcholine muscarinic antagonist | 0.234 0.017 DBMET00358 0.517 0.004 DB01515 0.622 0.003 DBMET00645 | DBMET00645 | |
| 0.545 | 0.004 | 0.545 | Acetylcholine nicotinic antagonist | 0.22 0.011 DBMET00358 0.375 0.005 DB01515 0.499 0.004 DBMET00645 | ||
| 0.528 | 0.004 | 0.581 | 5 Hydroxytryptamine uptake stimulant | 0.387 0.017 DBMET00358 0.581 0.003 DB01515 0.477 0.005 DBMET00645 | DB01515 | |
| 0.53 | 0.041 | 0.609 | Analgesic | 0.419 0.076 DBMET00358 0.609 0.025 DB01515 0.507 0.047 DBMET00645 | DB01515 | |
| 0.483 | 0.011 | 0.483 | Sigma receptor agonist | 0.126 0.107 DBMET00358 0.436 0.017 DB01515 0.422 0.019 DBMET00645 | ||
| 0.421 | 0.02 | 0.421 | Vasodilator | 0.155 0.15 DBMET00358 0.328 0.039 DB01515 0.416 0.02 DBMET00645 | ||
| 0.438 | 0.057 | 0.501 | Calcium channel L-type activator | 0.501 0.027 DBMET00358 0.335 0.129 DBMET00645 | DBMET00358 | |
| 0.373 | 0.004 | 0.373 | Neuronal nicotinic receptor antagonist | 0.175 0.01 DBMET00358 0.258 0.006 DB01515 0.275 0.005 DBMET00645 | ||
| 0.385 | 0.031 | 0.428 | Calcium channel activator | 0.428 0.016 DBMET00358 0.239 0.161 DB01515 0.371 0.037 DBMET00645 | DBMET00358 | |
| 0.352 | 0.008 | 0.352 | DNA polymerase I inhibitor | 0.152 0.048 DBMET00358 0.313 0.01 DB01515 0.304 0.011 DBMET00645 | ||
| 0.357 | 0.02 | 0.357 | P-glycoprotein inhibitor | 0.28 0.033 DB01515 0.315 0.026 DBMET00645 | ||
| 0.346 | 0.011 | 0.473 | 5 Hydroxytryptamine 1E antagonist | 0.473 0.004 DBMET00358 0.246 0.079 DB01515 0.252 0.072 DBMET00645 | DBMET00358 | |
| 0.369 | 0.054 | 0.42 | Immunomodulator | 0.42 0.038 DB01515 0.371 0.053 DBMET00645 | DB01515 | |
| 0.301 | 0.004 | 0.341 | Acetylcholine M2 receptor antagonist | 0.129 0.015 DBMET00358 0.162 0.01 DB01515 0.341 0.004 DBMET00645 | DBMET00645 | |
| 0.295 | 0.003 | 0.295 | Nicotinic alpha4beta2 receptor antagonist | 0.18 0.005 DBMET00358 0.166 0.005 DB01515 0.205 0.004 DBMET00645 | ||
| 0.334 | 0.081 | 0.334 | Vasodilator, peripheral | 0.284 0.105 DB01515 0.315 0.089 DBMET00645 | ||
| 0.253 | 0.007 | 0.253 | Opioid kappa receptor antagonist | 0.104 0.031 DBMET00358 0.212 0.009 DB01515 0.193 0.011 DBMET00645 | ||
| 0.234 | 0.005 | 0.254 | Acetylcholine M3 receptor antagonist | 0.076 0.028 DBMET00358 0.187 0.008 DB01515 0.254 0.005 DBMET00645 | DBMET00645 | |
| 0.232 | 0.019 | 0.232 | ATPase inhibitor | 0.184 0.053 DB01515 0.223 0.023 DBMET00645 | ||
| 0.299 | 0.088 | 0.334 | Vasodilator, coronary | 0.22 0.164 DBMET00358 0.251 0.134 DB01515 0.334 0.064 DBMET00645 | DBMET00645 | |
| 0.206 | 0.005 | 0.206 | Nicotinic receptor alpha3 subunit antagonist | 0.096 0.01 DBMET00358 0.108 0.009 DB01515 0.129 0.008 DBMET00645 | ||
| 0.204 | 0.005 | 0.228 | Acetylcholine M4 receptor antagonist | 0.15 0.01 DBMET00358 0.1 0.029 DB01515 0.228 0.005 DBMET00645 | DBMET00645 | |
| 0.25 | 0.066 | 0.337 | DNA synthesis inhibitor | 0.276 0.053 DBMET00358 0.337 0.033 DB01515 0.243 0.071 DBMET00645 | DB01515 | |
| 0.283 | 0.102 | 0.399 | Cholesterol antagonist | 0.399 0.05 DB01515 0.356 0.062 DBMET00645 | DB01515 | |
| 0.218 | 0.039 | 0.218 | Cytidine deaminase inhibitor | 0.117 0.103 DB01515 0.185 0.054 DBMET00645 | ||
| 0.189 | 0.016 | 0.189 | Opioid antagonist | 0.084 0.064 DBMET00358 0.173 0.019 DB01515 0.154 0.025 DBMET00645 | ||
| 0.177 | 0.011 | 0.177 | Analgesic, opioid | 0.104 0.029 DBMET00358 0.156 0.014 DB01515 0.148 0.015 DBMET00645 | ||
| 0.181 | 0.025 | 0.267 | Expectorant | 0.12 0.051 DBMET00358 0.267 0.011 DB01515 0.197 0.021 DBMET00645 | DB01515 | |
| 0.168 | 0.016 | 0.206 | Prolactin inhibitor | 0.206 0.008 DB01515 0.158 0.019 DBMET00645 | DB01515 | |
| 0.171 | 0.022 | 0.171 | Protein kinase C gamma inhibitor | 0.167 0.023 DB01515 0.118 0.054 DBMET00645 | ||
| 0.153 | 0.004 | 0.153 | Nicotinic alpha3beta2 receptor antagonist | 0.086 0.011 DBMET00358 0.12 0.005 DB01515 0.123 0.005 DBMET00645 | ||
| 0.171 | 0.022 | 0.171 | Antineoplastic alkaloid | 0.132 0.033 DBMET00358 0.133 0.033 DB01515 0.11 0.042 DBMET00645 | ||
| 0.151 | 0.005 | 0.151 | Opioid kappa receptor agonist | 0.04 0.034 DBMET00358 0.074 0.014 DB01515 0.087 0.011 DBMET00645 | ||
| 0.151 | 0.007 | 0.151 | Protein kinase C eta inhibitor | 0.149 0.008 DB01515 0.13 0.01 DBMET00645 | ||
| 0.143 | 0.007 | 0.143 | Nicotinic receptor alpha7 subunit antagonist | 0.054 0.036 DBMET00358 0.131 0.008 DB01515 0.109 0.011 DBMET00645 | ||
| 0.138 | 0.011 | 0.138 | ATPase (Vacuolar H+) inhibitor | 0.134 0.012 DB01515 0.13 0.014 DBMET00645 | ||
| 0.218 | 0.104 | 0.236 | Cardiotonic | 0.2 0.119 DB01515 0.236 0.092 DBMET00645 | DBMET00645 | |
| 0.127 | 0.012 | 0.127 | 5 Hydroxytryptamine 3 antagonist | 0.083 0.023 DB01515 0.107 0.016 DBMET00645 | ||
| 0.147 | 0.033 | 0.147 | Photosensitizer | 0.12 0.057 DB01515 0.144 0.034 DBMET00645 | ||
| 0.151 | 0.041 | 0.173 | Ca2+-transporting ATPase inhibitor | 0.173 0.011 DB01515 0.159 0.025 DBMET00645 | DB01515 | |
| 0.148 | 0.039 | 0.148 | Microtubule formation inhibitor | 0.104 0.084 DBMET00358 0.137 0.046 DB01515 0.136 0.046 DBMET00645 | ||
| 0.135 | 0.031 | 0.166 | Acetylcholine agonist | 0.127 0.034 DBMET00358 0.079 0.067 DB01515 0.166 0.022 DBMET00645 | DBMET00645 | |
| 0.114 | 0.011 | 0.114 | 5 Hydroxytryptamine 3A antagonist | 0.096 0.019 DB01515 0.099 0.017 DBMET00645 | ||
| 0.126 | 0.023 | 0.13 | Opioid mu receptor antagonist | 0.13 0.022 DB01515 0.103 0.031 DBMET00645 | DB01515 | |
| 0.115 | 0.014 | 0.115 | Sigma receptor antagonist | 0.089 0.018 DB01515 0.101 0.016 DBMET00645 | ||
| 0.132 | 0.032 | 0.132 | Acetylcholine release stimulant | 0.106 0.075 DB01515 0.13 0.034 DBMET00645 | ||
| 0.193 | 0.094 | 0.442 | HERG channel blocker | 0.442 0.022 DBMET00358 0.165 0.115 DBMET00645 | DBMET00358 | |
| 0.16 | 0.061 | 0.168 | Protein kinase stimulant | 0.111 0.104 DBMET00358 0.168 0.057 DB01515 0.129 0.085 DBMET00645 | DB01515 | |
| 0.148 | 0.05 | 0.161 | Cyclooxygenase 3 inhibitor | 0.161 0.04 DB01515 0.153 0.046 DBMET00645 | DB01515 | |
| 0.138 | 0.04 | 0.206 | Mucolytic | 0.103 0.073 DBMET00358 0.206 0.012 DB01515 0.165 0.025 DBMET00645 | DB01515 | |
| 0.103 | 0.012 | 0.105 | Protein kinase C beta inhibitor | 0.105 0.012 DB01515 0.081 0.028 DBMET00645 | DB01515 | |
| 0.097 | 0.007 | 0.105 | 5 Hydroxytryptamine 4 antagonist | 0.091 0.009 DB01515 0.105 0.005 DBMET00645 | DBMET00645 | |
| 0.128 | 0.04 | 0.128 | Bronchodilator | 0.116 0.048 DB01515 0.107 0.056 DBMET00645 | ||
| 0.277 | 0.19 | 0.277 | Apoptosis agonist | 0.243 0.222 DB01515 | ||
| 0.103 | 0.017 | 0.117 | Acetylcholine M5 receptor antagonist | 0.06 0.043 DB01515 0.117 0.013 DBMET00645 | DBMET00645 | |
| 0.131 | 0.045 | 0.223 | Chelator | 0.223 0.02 DB01515 0.134 0.043 DBMET00645 | DB01515 | |
| 0.12 | 0.035 | 0.159 | Acetylcholine M3 receptor agonist | 0.159 0.015 DBMET00358 0.075 0.065 DB01515 0.134 0.028 DBMET00645 | DBMET00358 | |
| 0.103 | 0.018 | 0.117 | Acetylcholine M5 receptor agonist | 0.058 0.057 DBMET00358 0.063 0.051 DB01515 0.117 0.012 DBMET00645 | DBMET00645 | |
| 0.093 | 0.009 | 0.23 | Nicotinic receptor alpha4 subunit antagonist | 0.23 0.003 DBMET00358 0.078 0.014 DB01515 0.078 0.014 DBMET00645 | DBMET00358 | |
| 0.098 | 0.018 | 0.146 | Acetylcholine muscarinic agonist | 0.072 0.026 DBMET00358 0.146 0.01 DBMET00645 | DBMET00645 | |
| 0.164 | 0.085 | 0.164 | Nitric oxide antagonist | 0.147 0.098 DB01515 0.142 0.103 DBMET00645 | ||
| 0.134 | 0.057 | 0.134 | 5 Hydroxytryptamine antagonist | 0.1 0.078 DBMET00645 | ||
| 0.182 | 0.11 | 0.414 | Potassium channel (Voltage-sensitive) blocker | 0.414 0.025 DBMET00358 | DBMET00358 | |
| 0.085 | 0.017 | 0.085 | Opioid agonist | 0.059 0.03 DBMET00358 0.06 0.029 DB01515 0.06 0.03 DBMET00645 | ||
| 0.132 | 0.067 | 0.323 | Alpha-N-acetylglucosaminidase inhibitor | 0.323 0.014 DB01515 0.176 0.042 DBMET00645 | DB01515 | |
| 0.07 | 0.008 | 0.07 | Sigma 1 receptor antagonist | 0.047 0.011 DB01515 0.058 0.009 DBMET00645 | ||
| 0.216 | 0.154 | 0.257 | Transcription factor NF kappa B inhibitor | 0.205 0.164 DB01515 0.257 0.122 DBMET00645 | DBMET00645 | |
| 0.105 | 0.044 | 0.118 | Calcium antagonist | 0.118 0.036 DBMET00645 | DBMET00645 | |
| 0.132 | 0.075 | 0.16 | Calcium channel blocker | 0.11 0.099 DBMET00358 0.16 0.051 DBMET00645 | DBMET00645 | |
| 0.089 | 0.033 | 0.1 | Opioid delta receptor antagonist | 0.1 0.03 DB01515 0.068 0.041 DBMET00645 | DB01515 | |
| 0.07 | 0.014 | 0.12 | 5-Alpha-reductase inhibitor | 0.058 0.016 DBMET00358 0.12 0.008 DB01515 0.075 0.013 DBMET00645 | DB01515 | |
| 0.157 | 0.103 | 0.16 | Hepatoprotectant | 0.16 0.099 DB01515 0.154 0.106 DBMET00645 | DB01515 | |
| 0.071 | 0.019 | 0.113 | Acetylcholine M1 receptor agonist | 0.044 0.029 DBMET00358 0.113 0.011 DBMET00645 | DBMET00645 | |
| 0.063 | 0.011 | 0.13 | Nicotinic receptor beta4 subunit antagonist | 0.13 0.005 DBMET00358 0.065 0.01 DB01515 0.058 0.013 DBMET00645 | DBMET00358 | |
| 0.159 | 0.113 | 0.159 | Antimitotic | |||
| 0.154 | 0.11 | 0.166 | Non-steroidal antiinflammatory agent | 0.166 0.099 DB01515 0.157 0.106 DBMET00645 | DB01515 | |
| 0.058 | 0.017 | 0.059 | Microtubule stabilization | 0.059 0.015 DB01515 0.057 0.018 DBMET00645 | DB01515 | |
| 0.045 | 0.005 | 0.047 | Protein kinase C beta I inhibitor | 0.047 0.005 DB01515 0.044 0.006 DBMET00645 | DB01515 | |
| 0.052 | 0.013 | 0.057 | 5 Hydroxytryptamine 3B antagonist | 0.043 0.018 DB01515 0.057 0.012 DBMET00645 | DBMET00645 | |
| 0.166 | 0.127 | 0.2 | Cyclic AMP phosphodiesterase inhibitor | 0.179 0.112 DBMET00358 0.171 0.121 DB01515 0.2 0.094 DBMET00645 | DBMET00645 | |
| 0.052 | 0.013 | 0.076 | Farnesoid X receptor agonist | 0.076 0.006 DB01515 0.06 0.01 DBMET00645 | DB01515 | |
| 0.207 | 0.169 | 0.285 | Antithrombotic | 0.285 0.099 DB01515 0.254 0.123 DBMET00645 | DB01515 | |
| 0.078 | 0.042 | 0.102 | Calcium channel L-type blocker | 0.102 0.023 DBMET00358 0.102 0.024 DBMET00645 | DBMET00645 | |
| 0.146 | 0.111 | 0.197 | Lipocortins synthesis antagonist | 0.195 0.06 DB01515 0.197 0.058 DBMET00645 | DBMET00645 | |
| 0.135 | 0.101 | 0.139 | Interferon gamma antagonist | 0.135 0.102 DBMET00358 0.139 0.095 DB01515 | DB01515 | |
| 0.193 | 0.16 | 0.228 | Gastrin inhibitor | 0.186 0.17 DBMET00358 0.228 0.108 DB01515 0.201 0.148 DBMET00645 | DB01515 | |
| 0.143 | 0.112 | 0.143 | DNA methyltransferase I inhibitor | 0.131 0.128 DB01515 0.138 0.118 DBMET00645 | ||
| 0.109 | 0.079 | 0.109 | Alkylator | 0.097 0.091 DB01515 | ||
| 0.133 | 0.104 | 0.149 | Heat shock protein 70 antagonist | 0.149 0.049 DB01515 | DB01515 | |
| 0.272 | 0.243 | 0.416 | Antiinflammatory | 0.416 0.13 DB01515 | DB01515 | |
| 0.082 | 0.056 | 0.082 | Antineoplastic antibiotic | 0.077 0.059 DB01515 | ||
| 0.081 | 0.055 | 0.114 | Glycine receptor antagonist | 0.114 0.022 DB01515 | DB01515 | |
| 0.059 | 0.034 | 0.059 | Acetyl-CoA transferase 2 inhibitor | 0.058 0.035 DB01515 0.057 0.037 DBMET00645 | ||
| 0.038 | 0.013 | 0.04 | Protein kinase C beta II inhibitor | 0.04 0.011 DB01515 0.036 0.016 DBMET00645 | DB01515 | |
| 0.072 | 0.05 | 0.097 | Glycine receptor agonist | 0.097 0.023 DB01515 0.066 0.064 DBMET00645 | DB01515 | |
| 0.096 | 0.077 | 0.096 | Toll-Like receptor 4 antagonist | 0.096 0.078 DBMET00645 | ||
| 0.144 | 0.127 | 0.171 | Angiogenesis stimulant | 0.171 0.11 DB01515 | DB01515 | |
| 0.027 | 0.01 | 0.027 | 5 Hydroxytryptamine 4 agonist | 0.023 0.022 DB01515 0.026 0.013 DBMET00645 | ||
| 0.047 | 0.032 | 0.047 | Opioid mu receptor agonist | 0.044 0.034 DB01515 | ||
| 0.052 | 0.038 | 0.056 | Protein 50S ribosomal subunit inhibitor | 0.056 0.034 DB01515 | DB01515 | |
| 0.086 | 0.072 | 0.145 | Glutamate release inhibitor | 0.145 0.011 DBMET00358 | DBMET00358 | |
| 0.092 | 0.077 | 0.099 | Nav1.1 sodium channel blocker | 0.099 0.067 DBMET00645 | DBMET00645 | |
| 0.052 | 0.039 | 0.066 | Alpha-mannosidase inhibitor | 0.066 0.02 DB01515 0.055 0.034 DBMET00645 | DB01515 | |
| 0.104 | 0.093 | 0.113 | Nav1.3 sodium channel blocker | 0.113 0.081 DBMET00645 | DBMET00645 | |
| 0.042 | 0.031 | 0.264 | Dopamine D5 antagonist | 0.264 0.004 DBMET00358 | DBMET00358 | |
| 0.034 | 0.025 | 0.036 | Tubulin agonist | 0.036 0.021 DB01515 | DB01515 | |
| 0.02 | 0.011 | 0.061 | 5-Alpha-reductase 1 inhibitor | 0.022 0.01 DBMET00358 0.061 0.006 DB01515 0.019 0.011 DBMET00645 | DB01515 | |
| 0.089 | 0.081 | 0.117 | Anabolic | 0.117 0.042 DB01515 0.107 0.053 DBMET00645 | DB01515 | |
| 0.055 | 0.048 | 0.056 | Lipocortins synthesis agonist | 0.054 0.053 DB01515 0.056 0.044 DBMET00645 | DBMET00645 | |
| 0.02 | 0.013 | 0.067 | 5-Alpha-reductase 2 inhibitor | 0.022 0.011 DBMET00358 0.067 0.006 DB01515 0.019 0.014 DBMET00645 | DB01515 | |
| 0.076 | 0.07 | 0.085 | GABA A receptor agonist | 0.085 0.055 DBMET00645 | DBMET00645 | |
| 0.046 | 0.041 | 0.053 | HCV NS3/NS4A protease inhibitor | 0.053 0.028 DB01515 | DB01515 | |
| 0.072 | 0.067 | 0.095 | Acetylcholine nicotinic agonist | 0.095 0.041 DBMET00358 0.074 0.065 DB01515 | DBMET00358 | |
| 0.028 | 0.024 | 0.031 | Nicotinic alpha3beta4 receptor agonist | 0.031 0.02 DBMET00358 | DBMET00358 | |
| 0.029 | 0.025 | 0.031 | Elastase 3A inhibitor | 0.031 0.02 DBMET00358 0.031 0.021 DBMET00645 | DBMET00645 | |
| 0.029 | 0.025 | 0.031 | Elastase 2B inhibitor | 0.031 0.02 DBMET00358 0.031 0.021 DBMET00645 | DBMET00645 | |
| 0.029 | 0.025 | 0.031 | Elastase 3B inhibitor | 0.031 0.02 DBMET00358 0.031 0.021 DBMET00645 | DBMET00645 | |
| 0.039 | 0.035 | 0.065 | Guanylate cyclase inhibitor | 0.042 0.03 DBMET00358 0.065 0.008 DB01515 | DB01515 | |
| 0.106 | 0.102 | 0.129 | Nav1.2 sodium channel blocker | 0.118 0.086 DB01515 0.129 0.074 DBMET00645 | DBMET00645 | |
| 0.2 | 0.197 | 0.319 | Immunosuppressant | 0.319 0.103 DB01515 | DB01515 | |
| 0.062 | 0.06 | 0.094 | Glutamate (mGluR7) antagonist | 0.094 0.014 DB01515 | DB01515 | |
| 0.196 | 0.196 | 0.281 | Interleukin 2 agonist | 0.281 0.088 DB01515 0.214 0.166 DBMET00645 | DB01515 | |
| 0.088 | 0.093 | 0.119 | Adenylate kinase inhibitor | 0.119 0.044 DB01515 0.09 0.088 DBMET00645 | DB01515 | |
| 0.192 | 0.199 | 0.242 | Sodium/bile acid cotransporter inhibitor | 0.242 0.137 DB01515 | DB01515 | |
| 0.056 | 0.064 | 0.36 | 5 Hydroxytryptamine 1F antagonist | 0.36 0.005 DBMET00358 | DBMET00358 | |
| 0.025 | 0.033 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.017 DB01515 | DB01515 | |
| 0.049 | 0.058 | 0.055 | Androgen agonist | 0.055 0.049 DB01515 0.054 0.049 DBMET00645 | DB01515 | |
| 0.02 | 0.03 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.02 DB01515 | DB01515 | |
| 0.022 | 0.034 | 0.027 | HCV NS5A inhibitor | 0.027 0.022 DBMET00358 | DBMET00358 | |
| 0.035 | 0.052 | 0.054 | Mannosidase inhibitor | 0.054 0.021 DB01515 | DB01515 | |
| 0.076 | 0.094 | 0.084 | Sphingomyelinase inhibitor | 0.084 0.081 DB01515 | DB01515 | |
| 0.083 | 0.102 | 0.102 | GABA receptor agonist | 0.102 0.075 DBMET00645 | DBMET00645 | |
| 0.019 | 0.04 | 0.031 | Acetylcholine M4 receptor agonist | 0.031 0.02 DBMET00645 | DBMET00645 | |
| 0.057 | 0.08 | 0.083 | Glutamate (mGluR6) antagonist | 0.072 0.035 DBMET00358 0.083 0.021 DB01515 0.073 0.034 DBMET00645 | DB01515 | |
| 0.018 | 0.042 | 0.043 | Nicotinic alpha4beta2 receptor agonist | 0.043 0.006 DBMET00358 | DBMET00358 | |
| 0.112 | 0.137 | 0.128 | Arachidonic acid antagonist | 0.123 0.122 DBMET00358 0.128 0.115 DB01515 | DB01515 | |
| 0.171 | 0.197 | 0.216 | Tyrosine 3 hydroxylase inhibitor | 0.216 0.11 DBMET00358 0.211 0.116 DB01515 0.213 0.113 DBMET00645 | DBMET00358 | |
| 0.039 | 0.065 | 0.054 | Acetylcholine M2 receptor agonist | 0.054 0.037 DBMET00645 | DBMET00645 | |
| 0.015 | 0.041 | 0.025 | RNA-directed RNA polymerase stimulant | 0.025 0.024 DBMET00358 | DBMET00358 | |
| 0.156 | 0.184 | 0.228 | RNA-directed DNA polymerase inhibitor | 0.228 0.066 DBMET00358 | DBMET00358 | |
| 0.037 | 0.074 | 0.082 | Aconitate hydratase inhibitor | 0.082 0.013 DB01515 | DB01515 | |
| 0.024 | 0.063 | 0.058 | Glutamate (mGluR3) antagonist | 0.058 0.009 DB01515 | DB01515 | |
| 0.014 | 0.053 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DB01515 | DB01515 | |
| 0.024 | 0.063 | 0.036 | Glutamate (mGluR3) agonist | 0.03 0.029 DBMET00358 0.036 0.015 DB01515 | DB01515 | |
| 0.075 | 0.116 | 0.105 | Cystathionine beta-synthase inhibitor | 0.105 0.071 DB01515 | DB01515 | |
| 0.098 | 0.142 | 0.19 | Cholinergic | 0.19 0.051 DBMET00358 | DBMET00358 | |
| 0.078 | 0.128 | 0.099 | Calcium channel (voltage-sensitive) blocker | 0.099 0.085 DBMET00645 | DBMET00645 | |
| 0.065 | 0.118 | 0.137 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.084 0.074 DBMET00358 0.137 0.031 DB01515 | DB01515 | |
| 0.007 | 0.07 | 0.015 | Nicotinic alpha4 receptor agonist | 0.015 0.013 DBMET00358 | DBMET00358 | |
| 0.124 | 0.19 | 0.19 | Interleukin agonist | 0.19 0.13 DB01515 0.167 0.152 DBMET00645 | DB01515 | |
| 0.07 | 0.138 | 0.104 | Cholesterol synthesis inhibitor | 0.104 0.082 DB01515 | DB01515 | |
| 0.026 | 0.1 | 0.073 | Plasminogen activator inhibitor antagonist | 0.073 0.017 DB01515 | DB01515 | |
| 0.041 | 0.119 | 0.071 | Histamine H1 receptor antagonist | 0.071 0.067 DB01515 | DB01515 | |
| 0.024 | 0.102 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.028 DB01515 | DB01515 | |
| 0.038 | 0.12 | 0.058 | Cathepsin E inhibitor | 0.058 0.044 DBMET00358 | DBMET00358 | |
| 0.132 | 0.219 | 0.184 | 5 Hydroxytryptamine release stimulant | 0.184 0.136 DBMET00645 | DBMET00645 | |
| 0.028 | 0.116 | 0.049 | Glutamate (mGluR group III) antagonist | 0.049 0.022 DB01515 | DB01515 | |
| 0.057 | 0.149 | 0.11 | Triose-phosphate isomerase inhibitor | 0.11 0.039 DB01515 | DB01515 | |
| 0.063 | 0.156 | 0.089 | Electrolyte absorption antagonist | 0.089 0.077 DB01515 | DB01515 | |
| 0.009 | 0.105 | 0.112 | Dipeptidyl peptidase I inhibitor | 0.112 0.004 DBMET00358 | DBMET00358 | |
| 0.043 | 0.14 | 0.077 | Ornithine decarboxylase inhibitor | 0.077 0.071 DBMET00645 | DBMET00645 | |
| 0.068 | 0.17 | 0.091 | Glutamate (mGluR7) agonist | 0.091 0.081 DBMET00358 | DBMET00358 | |
| 0.06 | 0.162 | 0.106 | Adenylate cyclase inhibitor | 0.106 0.079 DB01515 | DB01515 | |
| 0.007 | 0.119 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.015 0.01 DBMET00358 | DBMET00358 | |
| 0.055 | 0.176 | 0.093 | Bile acid receptor antagonist | 0.093 0.065 DB01515 | DB01515 | |
| 0.09 | 0.219 | 0.248 | Potassium channel blocker | 0.248 0.067 DBMET00358 | DBMET00358 | |
| 0.086 | 0.225 | 0.137 | GABA C receptor rho-2 antagonist | 0.137 0.093 DBMET00358 | DBMET00358 | |
| 0.038 | 0.177 | 0.073 | Glutamate dehydrogenase inhibitor | 0.073 0.052 DB01515 | DB01515 | |
| 0.052 | 0.198 | 0.087 | GABA C receptor rho-1 antagonist | 0.087 0.083 DBMET00358 | DBMET00358 | |
| 0.044 | 0.194 | 0.107 | Creatine kinase inhibitor | 0.107 0.052 DB01515 | DB01515 | |
| 0.047 | 0.197 | 0.152 | GABA C receptor agonist | 0.12 0.049 DBMET00358 0.152 0.033 DB01515 | DB01515 | |
| 0.052 | 0.209 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | 0.092 0.048 DBMET00358 | DBMET00358 | |
| 0.072 | 0.23 | 0.142 | Cell wall synthesis inhibitor | 0.142 0.073 DB01515 | DB01515 | |
| 0.02 | 0.18 | 0.067 | Glutamate (mGluR8) antagonist | 0.067 0.004 DBMET00358 0.054 0.007 DB01515 | DBMET00358 | |
| 0.045 | 0.207 | 0.093 | UDP-glucose 4-epimerase inhibitor | 0.093 0.069 DB01515 | DB01515 | |
| 0.049 | 0.212 | 0.079 | NADH dehydrogenase inhibitor | 0.079 0.078 DB01515 | DB01515 | |
| 0.018 | 0.184 | 0.052 | Neuraminidase (Influenza A) inhibitor | 0.052 0.022 DB01515 | DB01515 | |
| 0.054 | 0.225 | 0.116 | Thrombolytic | 0.116 0.115 DB01515 | DB01515 | |
| 0.027 | 0.202 | 0.065 | Transcription factor AP-1 inhibitor | 0.065 0.036 DBMET00645 | DBMET00645 | |
| 0.127 | 0.312 | 0.186 | Insulysin inhibitor | 0.186 0.179 DBMET00358 | DBMET00358 | |
| 0.136 | 0.323 | 0.229 | Antibacterial | 0.229 0.197 DB01515 | DB01515 | |
| 0.039 | 0.241 | 0.099 | Ferrochelatase inhibitor | 0.099 0.072 DB01515 | DB01515 | |
| 0.021 | 0.234 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.055 DB01515 | DB01515 | |
| 0.123 | 0.351 | 0.245 | Histamine release inhibitor | 0.245 0.159 DB01515 0.245 0.159 DBMET00645 | DBMET00645 | |
| 0.112 | 0.351 | 0.168 | Peptidyltransferase inhibitor | 0.168 0.151 DB01515 | DB01515 | |
| 0.149 | 0.409 | 0.287 | 5 Hydroxytryptamine release inhibitor | 0.287 0.181 DBMET00358 | DBMET00358 | |
| 0.057 | 0.325 | 0.116 | Sphingosine 1-phosphate receptor 4 antagonist | 0.116 0.081 DBMET00358 | DBMET00358 | |
| 0.016 | 0.304 | 0.078 | NMDA receptor antagonist | 0.078 0.068 DBMET00358 | DBMET00358 | |
| 0.032 | 0.427 | 0.316 | Hedgehog signaling inhibitor | 0.316 0.005 DBMET00358 | DBMET00358 | |
| 0.007 | 0.699 | 0.205 | M17 leucyl aminopeptidase inhibitor | 0.205 0.031 DBMET00358 | DBMET00358 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |